Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision made public on ...
Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of the ...
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...
Which Dow Jones Stock Is Cheaper, Amgen or Merck?
Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, ...
The HPV vaccine could eliminate 6 types of cancer. Why don’t more people get it?
The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA ...
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.
Is Merck Stock a Bargain Buy?
Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...
Nasdaq9d
Merck Loses Almost $52B in 6 Months: How to Play MRK Stock
Rising competitive pressure on the diabetes franchise and persistent challenges for its human papillomavirus vaccine, Gardasil in China remain overhangs. There are concerns about Merck’s ability ...